• NeuroThera Labs won a Japanese patent covering a proprietary drug combination designed to boost 4-aminophenol derivatives such as paracetamol.
• Patent covers pharmaceutical compositions and methods combining 4-aminophenol derivatives with N-acylethanolamines to improve analgesic and antipyretic effects.
• Company flagged potential for lower effective dosing, targeting reduced dose-related side-effect risk versus established 4-aminophenol-based therapies.
• Move expands IP protection in Japan as NeuroThera advances combination-therapy platforms for pain and fever across global markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurothera Labs Inc. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202608120802TNWSWRCACNPR_____1AJ6FQlpR) on August 12, 2026, and is solely responsible for the information contained therein.